ACCELERON PHARMA INC — key financial figures for fiscal year 2020 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2020)

$92.5M

Net Income/Loss (FY2020)

-$166.0M

Total Assets (FY2020)

$932.3M

Total Equity (FY2020)

$855.1M

Cash Flows from Operating Activities (FY2020)

-$130.3M

Source: ACCELERON PHARMA INC 10-K filing (FY2020). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.